CIK: 0000923093
A hedge fund manager recognized for his macroeconomic insights and trend-following trading strategies, especially within the futures markets.
| # | Form | Name | Filing Date |
|---|---|---|---|
|
01
|
13F-HR | Institutional Holdings Report | 11/14/2025 |
|
02
|
SCHEDULE 13G | Passive Investor Ownership Report | 10/14/2025 |
|
03
|
N-PX | N-PX | 09/02/2025 |
|
04
|
13F-HR | Institutional Holdings Report | 08/14/2025 |
|
05
|
13F-HR | Institutional Holdings Report | 05/15/2025 |
|
06
|
SCHEDULE 13G/A | Amendment to Passive Ownership Report | 03/05/2025 |
|
07
|
13F-HR | Institutional Holdings Report | 02/14/2025 |
A hedge fund manager recognized for his macroeconomic insights and trend-following trading strategies, especially within the futures markets.
Explore Paul Tudor Jones largest investments on Stocks.News, including companies like NVIDIA Corporation , Meta Platforms, Inc. , Seagen Inc. , and their significance in his portfolio.
Paul Tudor Jones portfolio updates are typically published quarterly through SEC 13F filings, which provide detailed information about their holdings, including recent buys and sells.
Paul Tudor Jones currently invests in companies such as Rocket Pharmaceuticals, Inc.
The largest holding in Paul Tudor Jones portfolio is NVIDIA Corporation.
As of Jun 30, 2025, Paul Tudor Jones portfolio is valued at approximately $45.92 B, based on the latest filings available on Stocks.News.